EV/EBIT - Mabwell Shanghai Bioscience Co Ltd (SSE:688062) - Alpha Spread
M

Mabwell Shanghai Bioscience Co Ltd
SSE:688062

Watchlist Manager
Mabwell Shanghai Bioscience Co Ltd
SSE:688062
Watchlist
Price: 21.24 CNY -0.28% Market Closed
Market Cap: 8.5B CNY
Have any thoughts about
Mabwell Shanghai Bioscience Co Ltd?
Write Note

EV/EBIT
Enterprise Value to EBIT

-7.8
Current
-8.2
Median
4.7
Industry
Higher than median
Lower than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
-7.8
=
Enterprise Value
8.1B CNY
/
EBIT
-1B CNY
All Countries
Close

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
-9.1
2-Years Forward
EV/EBIT
-10.5
3-Years Forward
EV/EBIT
-37.5

See Also

Discover More